update on phase i/ii study of glofitamab monotherapy in r/r mcl
Published 1 year ago • 57 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
2:43
insights into phase i/ii study assessing fixed-duration glofitamab treatment for r/r lbcl
-
1:39
phase i/ii trial of adct-602 in b-all
-
3:10
is there a benefit to rituximab maintenance after first-line bendamustine-rituximab for mcl?
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:31:46
openflow: cell proliferation by flow cytometry ii
-
9:25
mgus diagnosis: a step-by-step approach
-
9:44
cell cycle analysis
-
1:46
phase i study of costimulatory bispecific antibody ro7227166 combined with glofitamab in r/r b-nhl
-
1:00
updates on glofitamab in mcl
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
1:40
results from a phase i/ii study of golcadomide in r/r follicular lymphoma
-
2:23
results from the phase ii elm-2 trial: odronextamab for r/r follicular lymphoma
-
3:33
the growing role of machine learning in hematological oncology
-
2:53
considering the sequencing of covalent and non-covalent btk inhibitors in cll
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
5:07
daratumumab in the management of al amyloidosis
-
1:47
shared treatment decision-making
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
5:21
chemo-free regimens in lymphoma
-
0:42
targeted therapies for dlbcl treatment